Nigerian Stock Exchange
May & Baker Nigeria PLC · MAYBAKE.LG
May & Baker Nigeria Plc. is a pharmaceutical company, which is involved in the manufacturing, selling and distribution of human pharmaceuticals, human vaccines, and consumer products. The Company provides five types of products and services, including pharmaceuticals, beverages, personal care, naturecare, and contract manufacturing. Its durable business profile is anchored in local brands, manufacturing capacity, distribution relationships, product affordability and recurring consumer demand. Demand is linked to population growth, household income, pricing power, input costs and availability of raw materials. Investors should monitor volume trends, gross margins, working capital, competition, foreign-exchange exposure and the company’s ability to protect market share through quality and distribution. The company should be reviewed through its audited financial statements, corporate disclosures, operating segment notes and market announcements, because these materials provide the most reliable view of revenue quality, cost structure, capital allocation and any changes in business scope.
Fundamentals
connect to view moreSign in to unlock the full fundamentals history.
Sign in| Metric (NGN, B) | 2024 2024 | 2023 2023 | 2022 2022 | 2021 2021 | 2020 2020 |
|---|---|---|---|---|---|
| Revenue Total Revenue | 29 | ||||
| EBITDA | 3 | ||||
| EBIT | 2 | ||||
| Net income Net Income | 2 | ||||
| Operating margin | 8% | ||||
| Net margin | 6% |